February 21, 2017 12:23 AM ET

Biotechnology

Company Overview of MacroGenics, Inc.

Key Executives for MacroGenics, Inc.

NameBoard RelationshipsTitleAge
Scott Koenig M.D., Ph.D.24 RelationshipsChief Executive Officer, President and Director64
James Karrels No RelationshipsChief Financial Officer, Senior Vice President and Corporate Secretary49
Ezio Bonvini M.D.No RelationshipsChief Scientific Officer and Senior Vice President of Research62
Lynn Cilinski No RelationshipsVice President, Controller and Treasurer58
Eric Blasius Risser No RelationshipsChief Business Officer and Senior Vice President of Business Development & Portfolio Management43
View More Key Executives

MacroGenics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Paulo F. Costa 20 RelationshipsMacroGenics, Inc.65
Scott Koenig M.D., Ph.D. 24 RelationshipsMacroGenics, Inc.64
Edward M. Hurwitz J.D. 46 RelationshipsMPM Capital53
Kenneth H. Galbraith C.A. 75 RelationshipsFive Corners Capital Inc.53
Matthew K. Fust 45 RelationshipsSunesis Pharmaceuticals, Inc.51
View All Board Members

MacroGenics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Matthew K. Fust45 Relationships3 Executives
Compensation Committee J.D.Edward M. Hurwitz46 Relationships4 Executives
Nominating Committee C.A.Kenneth H. Galbraith75 Relationships4 Executives
Corporate Governance Committee C.A.Kenneth H. Galbraith75 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$523.0K
523.0K
353.8K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$523.0K
523.0K
19.5M
Compensation as of Fiscal Year 2015
MacroGenics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Kadmon Holdings Appoints Tasos G. Konidaris to Board of Directors
February 17, 2017 9:11 PM ET
Conatus Pharmaceuticals Inc. Announces Resignation of Charles J. Cashion as Senior Vice President, Finance, Chief Financial Officer and Secretary Effective from March 31, 2017
February 17, 2017 9:05 PM ET
Catabasis Pharmaceuticals, Inc. Announces Promotion of Ted Hibben to Chief Business Officer
February 17, 2017 1:00 PM ET
Botanix Pharmaceuticals Limited Announces Executive Changes
February 17, 2017 1:00 AM ET
Cancer Genetics, Inc. Appoints Igor Gitelman as New Principal Accounting Officer
February 16, 2017 10:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MacroGenics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.